By employing the linkage technique, several studies have developed imine-based anti-AD compounds that showed unbalanced dual-target inhibitory potency exhibiting strong MAO-B inhibition but little AChE inhibition [72]. This evidence concerns the gene ACHE and Alzheimer disease.